Fox Christine sold TEVA

April 30, 2026 · Form 4 insider transaction

Fox Christine sold 21,258 shares of Teva Pharmaceutical Industries Limited at $35.31 per share, a transaction worth $750.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
21,258
Price
$35.31
Total value
$750.6K
RoleOfficer
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateApril 30, 2026
Filing dateMay 4, 2026
Shares owned after63,647
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.28 to $35.33, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

View the original Form 4 on SEC EDGAR